- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 31/02 - Halogenated hydrocarbons
Patent holdings for IPC class A61K 31/02
Total number of patents in this class: 423
10-year publication summary
|
24
|
31
|
21
|
29
|
24
|
28
|
37
|
63
|
35
|
25
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Novaliq GmbH | 175 |
47 |
| NuVox Pharma, LLC | 32 |
24 |
| Amarin Pharmaceuticals Ireland Limited | 271 |
22 |
| Ruminant Biotech Corp Limited | 22 |
12 |
| Rumin8 Pty Ltd | 23 |
12 |
| Arvinas Operations, Inc. | 263 |
9 |
| Vapogenix, Inc. | 15 |
7 |
| The Regents of the University of California | 20802 |
6 |
| DSM IP Assets B.V. | 5385 |
6 |
| The Board of Regents of the University of Texas System | 2304 |
6 |
| ADS Therapeutics LLC | 56 |
6 |
| Abbvie Inc. | 1822 |
5 |
| FutureFeed Pty Ltd | 20 |
5 |
| University of Florida Research Foundation, Inc. | 4184 |
4 |
| Children's Medical Center Corporation | 1962 |
4 |
| Bioventures, LLC | 241 |
4 |
| Oneness Biotech Co., Ltd | 20 |
4 |
| Hoffmann-La Roche Inc. | 3815 |
3 |
| Genentech, Inc. | 4115 |
3 |
| The Johns Hopkins University | 5907 |
3 |
| Other owners | 231 |